TY - JOUR AU - Lim, S. Y. AU - Menzies, A. M. AU - Rizos, H. PY - 2017 DA - 2017// TI - Mechanisms and strategies to overcome resistance to molecularly targeted therapy for melanoma JO - Cancer VL - 123 UR - https://doi.org/10.1002/cncr.30435 DO - 10.1002/cncr.30435 ID - Lim2017 ER - TY - JOUR AU - Nikolaou, V. A. AU - Stratigos, A. J. AU - Flaherty, K. T. PY - 2012 DA - 2012// TI - Melanoma: new insights and new therapies JO - J Invest Dermatol VL - 132 UR - https://doi.org/10.1038/jid.2011.421 DO - 10.1038/jid.2011.421 ID - Nikolaou2012 ER - TY - JOUR AU - Dankner, M. AU - Rose, A. A. N. AU - Rajkumar, S. PY - 2018 DA - 2018// TI - Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations JO - Oncogene VL - 37 UR - https://doi.org/10.1038/s41388-018-0171-x DO - 10.1038/s41388-018-0171-x ID - Dankner2018 ER - TY - JOUR AU - Herbst, R. S. AU - Soria, J. C. AU - Kowanetz, M. PY - 2014 DA - 2014// TI - Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients JO - Nature VL - 515 UR - https://doi.org/10.1038/nature14011 DO - 10.1038/nature14011 ID - Herbst2014 ER - TY - JOUR AU - Greil, R. AU - Hutterer, E. AU - Hartmann, T. N. PY - 2017 DA - 2017// TI - Reactivation of dormant anti-tumor immunity - a clinical perspective of therapeutic immune checkpoint modulation JO - Cell Commun Signal VL - 15 UR - https://doi.org/10.1186/s12964-016-0155-9 DO - 10.1186/s12964-016-0155-9 ID - Greil2017 ER - TY - JOUR AU - Zou, W. AU - Wolchok, J. D. AU - Chen, L. PY - 2016 DA - 2016// TI - PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: mechanisms, response biomarkers, and combinations JO - Sci Transl Med VL - 8 UR - https://doi.org/10.1126/scitranslmed.aad7118 DO - 10.1126/scitranslmed.aad7118 ID - Zou2016 ER - TY - JOUR AU - Hamanishi, J. AU - Mandai, M. AU - Matsumura, N. PY - 2016 DA - 2016// TI - PD-1/PD-L1 blockade in cancer treatment: perspectives and issues JO - Int J Clin Oncol VL - 21 UR - https://doi.org/10.1007/s10147-016-0959-z DO - 10.1007/s10147-016-0959-z ID - Hamanishi2016 ER - TY - JOUR AU - Spranger, S. AU - Gajewski, T. F. PY - 2018 DA - 2018// TI - Impact of oncogenic pathways on evasion of antitumour immune responses JO - Nat Rev Cancer VL - 18 UR - https://doi.org/10.1038/nrc.2017.117 DO - 10.1038/nrc.2017.117 ID - Spranger2018 ER - TY - STD TI - Catakovic K, Klieser E, Neureiter D, et al. T cell exhaustion: from pathophysiological basics to tumor immunotherapy. Cell Commun Signal. 2017;15(1). ID - ref9 ER - TY - JOUR AU - Gong, J. AU - Chehrazi-Raffle, A. AU - Reddi, S. PY - 2018 DA - 2018// TI - Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations JO - J Immunother Cancer VL - 6 UR - https://doi.org/10.1186/s40425-018-0316-z DO - 10.1186/s40425-018-0316-z ID - Gong2018 ER - TY - JOUR AU - Sun, C. AU - Mezzadra, R. AU - Schumacher, T. N. PY - 2018 DA - 2018// TI - Regulation and function of the PD-L1 checkpoint JO - Immunity VL - 48 UR - https://doi.org/10.1016/j.immuni.2018.03.014 DO - 10.1016/j.immuni.2018.03.014 ID - Sun2018 ER - TY - JOUR AU - Zhou, Y. u. e. AU - Zheng, J. i. e. AU - Li, Y. a. AU - Xu, D. o. n. g. -. P. i. n. g. AU - Li, S. h. a. AU - Chen, Y. u. -. M. i. n. g. AU - Li, H. u. a. -. B. i. n. PY - 2016 DA - 2016// TI - Natural Polyphenols for Prevention and Treatment of Cancer JO - Nutrients VL - 8 UR - https://doi.org/10.3390/nu8080515 DO - 10.3390/nu8080515 ID - Zhou2016 ER - TY - JOUR AU - Shukla, S. AU - Gupta, S. PY - 2010 DA - 2010// TI - Apigenin: a promising molecule for cancer prevention JO - Pharm Res VL - 27 UR - https://doi.org/10.1007/s11095-010-0089-7 DO - 10.1007/s11095-010-0089-7 ID - Shukla2010 ER - TY - JOUR AU - Papay, Z. E. AU - Kosa, A. AU - Boddi, B. PY - 2017 DA - 2017// TI - Study on the pulmonary delivery system of Apigenin-loaded albumin Nanocarriers with antioxidant activity JO - J Aerosol Med Pulm Drug Deliv VL - 30 UR - https://doi.org/10.1089/jamp.2016.1316 DO - 10.1089/jamp.2016.1316 ID - Papay2017 ER - TY - JOUR AU - Wang, Y. C. AU - Huang, K. M. PY - 2013 DA - 2013// TI - In vitro anti-inflammatory effect of apigenin in the helicobacter pylori-infected gastric adenocarcinoma cells JO - Food Chem Toxicol VL - 53 UR - https://doi.org/10.1016/j.fct.2012.12.018 DO - 10.1016/j.fct.2012.12.018 ID - Wang2013 ER - TY - JOUR AU - Madunic, J. AU - Madunic, I. V. AU - Gajski, G. PY - 2018 DA - 2018// TI - Apigenin: a dietary flavonoid with diverse anticancer properties JO - Cancer Lett VL - 413 UR - https://doi.org/10.1016/j.canlet.2017.10.041 DO - 10.1016/j.canlet.2017.10.041 ID - Madunic2018 ER - TY - JOUR AU - Seo, H. -. S. AU - Jo, J. K. AU - Ku, J. M. AU - Choi, H. -. S. AU - Choi, Y. K. AU - Woo, J. -. K. AU - Kim, H. i. AU - Kang, S. -. y. AU - Lee, K. m. AU - Nam, K. W. AU - Park, N. AU - Jang, B. -. H. AU - Shin, Y. C. AU - Ko, S. -. G. PY - 2015 DA - 2015// TI - Induction of caspase-dependent extrinsic apoptosis by apigenin through inhibition of signal transducer and activator of transcription 3 (STAT3) signalling in HER2-overexpressing BT-474 breast cancer cells JO - Bioscience Reports VL - 35 UR - https://doi.org/10.1042/BSR20150165 DO - 10.1042/BSR20150165 ID - Seo2015 ER - TY - JOUR AU - Zhao, G. AU - Han, X. AU - Cheng, W. PY - 2017 DA - 2017// TI - Apigenin inhibits proliferation and invasion, and induces apoptosis and cell cycle arrest in human melanoma cells JO - Oncol Rep VL - 37 UR - https://doi.org/10.3892/or.2017.5450 DO - 10.3892/or.2017.5450 ID - Zhao2017 ER - TY - JOUR AU - Ruela-de-Sousa, R. R. AU - Fuhler, G. M. AU - Blom, N. PY - 2010 DA - 2010// TI - Cytotoxicity of apigenin on leukemia cell lines: implications for prevention and therapy JO - Cell Death Dis VL - 1 UR - https://doi.org/10.1038/cddis.2009.18 DO - 10.1038/cddis.2009.18 ID - Ruela-de-Sousa2010 ER - TY - JOUR AU - Gupta, S. AU - Afaq, F. AU - Mukhtar, H. PY - 2002 DA - 2002// TI - Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells JO - Oncogene VL - 21 UR - https://doi.org/10.1038/sj.onc.1205474 DO - 10.1038/sj.onc.1205474 ID - Gupta2002 ER - TY - JOUR AU - Granato, M. AU - Gilardini Montani, M. S. AU - Santarelli, R. PY - 2017 DA - 2017// TI - Apigenin, by activating p53 and inhibiting STAT3, modulates the balance between pro-apoptotic and pro-survival pathways to induce PEL cell death JO - J Exp Clin Cancer Res VL - 36 UR - https://doi.org/10.1186/s13046-017-0632-z DO - 10.1186/s13046-017-0632-z ID - Granato2017 ER - TY - JOUR AU - Zhang, Y. AU - Zhang, J. AU - Liu, C. PY - 2016 DA - 2016// TI - Neratinib induces ErbB2 ubiquitylation and endocytic degradation via HSP90 dissociation in breast cancer cells JO - Cancer Lett VL - 382 UR - https://doi.org/10.1016/j.canlet.2016.08.026 DO - 10.1016/j.canlet.2016.08.026 ID - Zhang2016 ER - TY - JOUR AU - Wang, M. AU - Zhang, Y. AU - Wang, T. PY - 2017 DA - 2017// TI - The USP7 inhibitor P5091 induces cell death in ovarian cancers with different P53 status JO - Cell Physiol Biochem VL - 43 UR - https://doi.org/10.1159/000484062 DO - 10.1159/000484062 ID - Wang2017 ER - TY - JOUR AU - Wang, T. AU - Zhang, J. AU - Wang, S. PY - 2018 DA - 2018// TI - The exon 19-deleted EGFR undergoes ubiquitylation-mediated endocytic degradation via dynamin activity-dependent and -independent mechanisms JO - Cell Commun Signal VL - 16 UR - https://doi.org/10.1186/s12964-018-0245-y DO - 10.1186/s12964-018-0245-y ID - Wang2018 ER - TY - JOUR AU - Yan, X. AU - Qi, M. AU - Li, P. PY - 2017 DA - 2017// TI - Apigenin in cancer therapy: anti-cancer effects and mechanisms of action JO - Cell Biosci VL - 7 UR - https://doi.org/10.1186/s13578-017-0179-x DO - 10.1186/s13578-017-0179-x ID - Yan2017 ER - TY - JOUR AU - Mirzaei, H. AU - Naseri, G. AU - Rezaee, R. PY - 2016 DA - 2016// TI - Curcumin: a new candidate for melanoma therapy? JO - Int J Cancer VL - 139 UR - https://doi.org/10.1002/ijc.30224 DO - 10.1002/ijc.30224 ID - Mirzaei2016 ER - TY - JOUR AU - Platanias, L. C. PY - 2005 DA - 2005// TI - Mechanisms of type-I- and type-II-interferon-mediated signalling JO - Nat Rev Immunol VL - 5 UR - https://doi.org/10.1038/nri1604 DO - 10.1038/nri1604 ID - Platanias2005 ER - TY - JOUR AU - Lin, H. AU - Wei, S. AU - Hurt, E. M. PY - 2018 DA - 2018// TI - Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression JO - J Clin Invest VL - 128 UR - https://doi.org/10.1172/JCI96113 DO - 10.1172/JCI96113 ID - Lin2018 ER - TY - JOUR AU - Teng, F. AU - Meng, X. AU - Kong, L. PY - 2018 DA - 2018// TI - Progress and challenges of predictive biomarkers of anti PD-1/PD-L1 immunotherapy: a systematic review JO - Cancer Lett VL - 414 UR - https://doi.org/10.1016/j.canlet.2017.11.014 DO - 10.1016/j.canlet.2017.11.014 ID - Teng2018 ER - TY - JOUR AU - Tang, H. AU - Liang, Y. AU - Anders, R. A. PY - 2018 DA - 2018// TI - PD-L1 on host cells is essential for PD-L1 blockade-mediated tumor regression JO - J Clin Invest VL - 128 UR - https://doi.org/10.1172/JCI96061 DO - 10.1172/JCI96061 ID - Tang2018 ER - TY - JOUR AU - Rezai-Zadeh, K. AU - Ehrhart, J. AU - Bai, Y. PY - 2008 DA - 2008// TI - Apigenin and luteolin modulate microglial activation via inhibition of STAT1-induced CD40 expression JO - J Neuroinflammation VL - 5 UR - https://doi.org/10.1186/1742-2094-5-41 DO - 10.1186/1742-2094-5-41 ID - Rezai-Zadeh2008 ER - TY - JOUR AU - Ginwala, R. AU - McTish, E. AU - Raman, C. PY - 2016 DA - 2016// TI - Apigenin, a natural flavonoid, attenuates EAE severity through the modulation of dendritic cell and other immune cell functions JO - J NeuroImmune Pharmacol VL - 11 UR - https://doi.org/10.1007/s11481-015-9617-x DO - 10.1007/s11481-015-9617-x ID - Ginwala2016 ER - TY - JOUR AU - Arango, D. AU - Morohashi, K. AU - Yilmaz, A. PY - 2013 DA - 2013// TI - Molecular basis for the action of a dietary flavonoid revealed by the comprehensive identification of apigenin human targets JO - Proc Natl Acad Sci U S A VL - 110 UR - https://doi.org/10.1073/pnas.1303726110 DO - 10.1073/pnas.1303726110 ID - Arango2013 ER - TY - JOUR AU - Schoenborn, J. R. AU - Wilson, C. B. PY - 2007 DA - 2007// TI - Regulation of interferon-gamma during innate and adaptive immune responses JO - Adv Immunol VL - 96 UR - https://doi.org/10.1016/S0065-2776(07)96002-2 DO - 10.1016/S0065-2776(07)96002-2 ID - Schoenborn2007 ER - TY - JOUR AU - Mandai, M. AU - Hamanishi, J. AU - Abiko, K. PY - 2016 DA - 2016// TI - Dual faces of IFNgamma in Cancer progression: a role of PD-L1 induction in the determination of pro- and antitumor immunity JO - Clin Cancer Res VL - 22 UR - https://doi.org/10.1158/1078-0432.CCR-16-0224 DO - 10.1158/1078-0432.CCR-16-0224 ID - Mandai2016 ER - TY - JOUR AU - Kharma, B. AU - Baba, T. AU - Matsumura, N. PY - 2014 DA - 2014// TI - STAT1 drives tumor progression in serous papillary endometrial cancer JO - Cancer Res VL - 74 UR - https://doi.org/10.1158/0008-5472.CAN-14-0847 DO - 10.1158/0008-5472.CAN-14-0847 ID - Kharma2014 ER - TY - JOUR AU - Ramana, C. V. AU - Gil, M. P. AU - Schreiber, R. D. PY - 2002 DA - 2002// TI - Stat1-dependent and -independent pathways in IFN-gamma-dependent signaling JO - Trends Immunol VL - 23 UR - https://doi.org/10.1016/S1471-4906(01)02118-4 DO - 10.1016/S1471-4906(01)02118-4 ID - Ramana2002 ER - TY - JOUR AU - Schmitt, M. J. AU - Philippidou, D. AU - Reinsbach, S. E. PY - 2012 DA - 2012// TI - Interferon-gamma-induced activation of signal transducer and activator of transcription 1 (STAT1) up-regulates the tumor suppressing microRNA-29 family in melanoma cells JO - Cell Commun Signal VL - 10 UR - https://doi.org/10.1186/1478-811X-10-41 DO - 10.1186/1478-811X-10-41 ID - Schmitt2012 ER - TY - JOUR AU - Mezzadra, R. AU - Sun, C. AU - Jae, L. T. PY - 2017 DA - 2017// TI - Identification of CMTM6 and CMTM4 as PD-L1 protein regulators JO - Nature VL - 549 UR - https://doi.org/10.1038/nature23669 DO - 10.1038/nature23669 ID - Mezzadra2017 ER - TY - JOUR AU - Coombs, M. R. AU - Harrison, M. E. AU - Hoskin, D. W. PY - 2016 DA - 2016// TI - Apigenin inhibits the inducible expression of programmed death ligand 1 by human and mouse mammary carcinoma cells JO - Cancer Lett VL - 380 UR - https://doi.org/10.1016/j.canlet.2016.06.023 DO - 10.1016/j.canlet.2016.06.023 ID - Coombs2016 ER - TY - JOUR AU - Spranger, S. AU - Koblish, H. K. AU - Horton, B. PY - 2014 DA - 2014// TI - Mechanism of tumor rejection with doublets of CTLA-4, PD-1/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8(+) T cells directly within the tumor microenvironment JO - J Immunother Cancer VL - 2 UR - https://doi.org/10.1186/2051-1426-2-3 DO - 10.1186/2051-1426-2-3 ID - Spranger2014 ER - TY - JOUR AU - Sheppard, K. A. AU - Fitz, L. J. AU - Lee, J. M. PY - 2004 DA - 2004// TI - PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3zeta signalosome and downstream signaling to PKCtheta JO - FEBS Lett VL - 574 UR - https://doi.org/10.1016/j.febslet.2004.07.083 DO - 10.1016/j.febslet.2004.07.083 ID - Sheppard2004 ER - TY - JOUR AU - Li, C. W. AU - Lim, S. O. AU - Xia, W. PY - 2016 DA - 2016// TI - Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity JO - Nat Commun VL - 7 UR - https://doi.org/10.1038/ncomms12632 DO - 10.1038/ncomms12632 ID - Li2016 ER - TY - JOUR AU - Ott, P. A. AU - Hodi, F. S. AU - Robert, C. PY - 2013 DA - 2013// TI - CTLA-4 and PD-1/PD-L1 blockade: new immunotherapeutic modalities with durable clinical benefit in melanoma patients JO - Clin Cancer Res VL - 19 UR - https://doi.org/10.1158/1078-0432.CCR-13-0143 DO - 10.1158/1078-0432.CCR-13-0143 ID - Ott2013 ER - TY - JOUR AU - Fujiki, H. AU - Watanabe, T. AU - Sueoka, E. PY - 2018 DA - 2018// TI - Cancer prevention with green tea and its principal constituent, EGCG: from early investigations to current focus on human Cancer stem cells JO - Mol Cells VL - 41 ID - Fujiki2018 ER - TY - JOUR AU - Rawangkan, A. n. c. h. a. l. e. e. AU - Wongsirisin, P. a. t. t. a. m. a. AU - Namiki, K. o. z. u. e. AU - Iida, K. e. i. s. u. k. e. AU - Kobayashi, Y. a. s. u. h. i. t. o. AU - Shimizu, Y. o. s. h. i. h. i. k. o. AU - Fujiki, H. i. r. o. t. a. AU - Suganuma, M. a. s. a. m. i. PY - 2018 DA - 2018// TI - Green Tea Catechin Is an Alternative Immune Checkpoint Inhibitor that Inhibits PD-L1 Expression and Lung Tumor Growth JO - Molecules VL - 23 UR - https://doi.org/10.3390/molecules23082071 DO - 10.3390/molecules23082071 ID - Rawangkan2018 ER -